Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-14-004725
Filing Date
2014-07-07
Accepted
2014-07-07 17:07:49
Documents
7
Effectiveness Date
2014-07-07

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT fs82014_actiniumpharma.htm S-8 557746
2 SPECIMEN COMMON STOCK CERTIFICATE fs82014ex4i_actiniumpharma.htm EX-4.1 2011
3 OPINION OF HISCOCK & BARCLAY, LLP fs82014ex5i_actiniumpharma.htm EX-5.1 10328
4 CONSENT OF GBH CPAS, PC fs82014ex23i_actiniumpharma.htm EX-23.1 3463
5 img1.jpg GRAPHIC 414310
6 img02.jpg GRAPHIC 302409
7 logo.jpg GRAPHIC 7982
  Complete submission text file 0001213900-14-004725.txt   1573428
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-197283 | Film No.: 14963533
SIC: 6770 Blank Checks